Last reviewed · How we verify
Immunosuppressants — Competitive Intelligence Brief
phase 2
Immunology
Small molecule
Live · refreshed every 30 min
Target snapshot
Immunosuppressants (Immunosuppressants) — Guang'anmen Hospital of China Academy of Chinese Medical Sciences.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Immunosuppressants TARGET | Immunosuppressants | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Immunosuppressants CI watch — RSS
- Immunosuppressants CI watch — Atom
- Immunosuppressants CI watch — JSON
- Immunosuppressants alone — RSS
Cite this brief
Drug Landscape (2026). Immunosuppressants — Competitive Intelligence Brief. https://druglandscape.com/ci/immunosuppressants. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing